Spodick D H
Am J Med. 1982 Sep;73(3):420-5. doi: 10.1016/0002-9343(82)90746-x.
Randomized controlled trials are increasingly accepted in principle but not always in practice, particularly for surgical therapies. Successful surgical randomized controlled trials demonstrate their feasibility, and reports of uncontrolled surgical trials now commonly bear a statement that a definitive answer requires a controlled trial. Scientifically, the randomized controlled trial is the most powerful way to determine a result ascribable only to the trial treatment. Although randomized controlled trials can be imperfect or improperly conducted, they are designed to circumvent biased behavior by investigators. With candor in informed consent, the equal chance not to get a trial treatment makes the randomized controlled trial the most ethical design. Thus, scientific, behavioral, and ethical cases support the randomized controlled trial as the optimal method for investigation of nearly all therapeutic innovations and as a requirement for publication.
随机对照试验原则上越来越被接受,但在实践中并非总是如此,尤其是对于外科治疗。成功的外科随机对照试验证明了其可行性,现在非对照外科试验的报告通常会声明,明确的答案需要进行对照试验。从科学角度来看,随机对照试验是确定仅归因于试验治疗的结果的最有力方法。尽管随机对照试验可能存在不完美或实施不当的情况,但它们旨在规避研究者的偏倚行为。通过知情同意中的坦诚,不接受试验治疗的平等机会使随机对照试验成为最符合伦理的设计。因此,科学、行为和伦理方面的理由都支持将随机对照试验作为几乎所有治疗创新研究的最佳方法以及发表的要求。